u/Stoiciism

was scrolling through PubMed on a Friday night like the nerd I am and found a post-hoc analysis of SURMOUNT-1 looking at liver fat. They did MRI-PDFF on a bunch of participants with NAFLD at baseline. Fancy MRI that actually measures fat percentage in your liver. The numbers are wild honestly. People on tirzepatide 10mg or 15mg had relative liver fat reductions of around 70%. Over 90% of people on the 15mg dose got down to normal liver fat levels (<5%). Ninety percent.

My hepatologist has been watching my liver enzymes for years. ALT used to be 85. Now it's 22. She kept saying "keep doing what you're doing" but never explained that my liver might actually be healing, not just getting less inflamed. I asked her about this at my last appointment. She said yeah, the imaging studies are showing actual regression of fibrosis in some patients. Not just less fat, but less scarring. I've been on Mounjaro for a year and apparently my liver is reversing decades of damage Wild.

everyone around me seems to have their peps figured out but i'm not even exaggerating when i say i'm running out of cash for rent trying to stay consistent. i really want to stick to high quality american made stuff because i care about what i'm using, but running a tesa and ipa stack is legit making me go broke. i'm 24 and really don't want to quit because i need this to get back to 100%, but i'm running out of options. the domestic markup is a joke. i'm fckn terrified i'm gonna be forced to stop entirely because i can't swing these payments anymore. what are you guys doing to stay on it without losing your place? i'm trying to prioritize my health but i can't go homeless over a few vials. smh.

I have commercial insurance that doesn't cover Zepbound. Cash price at CVS: $1,200. I Used the Zepbound savings card ( which takes $150 off). Also used a pharmacy discount card (GoodRx) that the pharmacist let me apply after the coupon. Total out of pocket price is 850, which is still expensive, but cheaper than 1,200.

The pharmacist said this doesn't always work. Some systems reject secondary cards. Some coupons prohibit stacking. But he tried it and it went through.

Občasno me boli križ. Ali uporablja kdo pas za hrbtenico in ali vam kaj pomaga? Flair: Splošno stanje in čakalne dobe

I have an appointment with my primary care doctor coming up and I am trying to figure out if I should actually tell him about the peptides I am taking. I am currently running some stuff prescribed by an anti-aging clinic, but I am also taking other peptides completely without a prescription. I really like my doctor and he is usually great at listening, but he is an older guy and I highly doubt he knows much about this stuff outside of thinking it is just for research. I am curious if you guys actually confide in your regular doctors about using unprescribed compounds. I decided I am just going to tell him this time, mostly because the main compound I am taking is technically prescribed by another doctor anyway so I am not just self-medicating, but I am still curious how everyone else handles this.

I'm a fat fuck who's been lifting but can't shed the weight. I need to lose 30 lbs. I found a good source that tests for metals and shit. Since I am totally new to this, I just want to know if this is actually legal. Am I going to get in trouble or anything if I order it?

A post-hoc analysis of the SURPASS-CVOT trial was presented at ACC 2026 and simultaneously published in JAMA Cardiology. The study compared tirzepatide to dulaglutide in over 13,000 patients with type 2 diabetes and established cardiovascular disease followed for a median of 47.4 months.

The primary analysis showed non-inferiority but not superiority on the narrow 3-component MACE endpoint. But this post-hoc analysis looked at a broader 6-component cardiorenal endpoint including all-cause mortality, MI, stroke, coronary revascularization, heart failure hospitalization, and adverse renal outcomes.

• The 6-component endpoint occurred in 23.7% of tirzepatide patients vs 27.4% on dulaglutide (HR 0.84, P <.001)

• All-cause mortality: 8.6% vs 10.2% (HR 0.84)

• Composite renal endpoint: 4.9% vs 6.1% (HR 0.79)

• Coronary revascularization: 8.0% vs 9.4% (HR 0.84)

Dr. Steven Nissen, the study author, said that "It's important to remember that the 0.84 hazard ratio... was not against placebo but against a very good drug that had already shown cardiovascular benefits. In that context, a 16% benefit is a big deal". I mean for me, my dad died of a heart attack at 62. This kind of data is why I stay on this medication even when the scale isn't moving.